Search
Soligenix Inc
SNGXAdd to Watchlist
0.396USD
-0.004-1.00%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
5.87MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-30The current earnings forecast score of Soligenix Inc is 8.00, ranking 165 out of 387 in the Biotechnology & Medical Research industry. The average price target is 17.50, with a high of 25.00 and a low of 10.00.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
6.000
Target Price
+1400.00%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
561
Total
5
Median
6
Average
Company name
Ratings
Analysts
Soligenix Inc
SNGX
1
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Soligenix Inc's price target?
Analysts forecast that Soligenix Inc's price target is USD 17.50, with the highest forecast at USD 25.00 and the lowest forecast at USD 10.00.
How have Soligenix IncSNGX's recent earnings per share performed?
The market expectation was USD -0.28, while Soligenix IncSNGX's earnings per share (EPS) for the previous quarter was USD -0.29. EPS for the next quarter is expected at USD -0.20.
What is the analyst rating for Soligenix Inc?
Based on the ratings of Soligenix Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
